David Schachter, MD
Interventional Cardiology · Tampa, FLNPI 1861466567
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $9,175 of the $12,516 with a category attached, or 73.3%. 14 manufacturers reported payments, led by Medtronic at 48.9% of the total. Reporting peaked in 2019 at $4,945 and has fallen 58.4% since, to $2,056 in 2025.
Across 104 payments — averaging $120.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- Penumbra, Inc.$3K
- Abbott$2K
- Abiomed$1K
- Boston Scientific$261
- E.r. Squibb & Sons, L.L.C.$135
- plus $357 from 8 others
What the payments were for
- Consulting fees$500%
- Travel & lodging$9,17573%
- Food & beverage$3,29126%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 53 | $6,121 |
| Penumbra, Inc. | 7 | $2,627 |
| Abbott | 11 | $1,539 |
| Abiomed | 12 | $1,478 |
| Boston Scientific | 3 | $261 |
| E.r. Squibb & Sons, L.L.C. | 2 | $135 |
| Asahi Intecc USA, Inc. | 1 | $120 |
| Pfizer | 4 | $50 |
| Stryker | 2 | $43 |
| W. L. Gore & Associates, Inc. | 1 | $42 |
| Inari Medical, Inc. | 2 | $40 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $28 |
| Chiesi USA, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo$4,418
- ONYX FRONTIER$2,684
- CoreValve Evolut$1,271
- AVEIR$1,102
- Resolute$1,003
- Impella$566
- CROSSBOSS$140
- CARDIOMEMS$128
- ASAHI PTCA Guide Wire$120
How this compares
$12,516 in reported general payments places this provider in the 60th percentile of 623 interventional cardiology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Tampa
- Jesal PopatTampa$206K
- Bibhu MohantyTampa$171K
- Saleem SaiyadTampa$107K
- Arthur LeeGainesville$1.8M
- Santhosh MathewsBradenton$1.4M
- Siddharth WayangankarJacksonville$1.2M
- Patrick CambierTrinity$901K
- Zahid AminOrlando$635K
- Rohit AminPensacola$560K
- Eduardo de MarchenaMiami$498K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.